-
-
-
-
-
-
-
Mizuho on Palvella Therapeutics (PVLA): remain bullish given QTORIN potential
-
-
-
-
-
-
-
Clear Street on Palvella Therapeutics (PVLA): 'We view this patent as incrementally positive'
-
-
-
-
-
-
-
Palvella Therapeutics (PVLA) PT Raised to $241 at Lucid Capital Markets
-
-
-
-
-
-
-
Palvella plans March 2026 data readout for rare skin disease drug
-
-
-
-
-
-
-
Palvella Therapeutics (PVLA) PT Raised to $192 at BTIG
-
-
-
-
-
-
-
Palvella Therapeutics (PVLA) PT Raised to $210 at Cantor Fitzgerald
-
-
-
-
-
-
-
Palvella Therapeutics (PVLA) PT Raised to $145 at Stifel
-
413,536 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

